These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2137022)

  • 21. Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
    Dolan ME; Pegg AE; Hora NK; Erickson LC
    Cancer Res; 1988 Jul; 48(13):3603-6. PubMed ID: 2837318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.
    Ali-Osman F; Srivenugopal K; Berger MS; Stein DE
    Anticancer Res; 1990; 10(3):677-82. PubMed ID: 2164350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
    Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
    Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil.
    Futscher BW; Campbell K; Dalton WS
    Cancer Res; 1992 Sep; 52(18):5013-7. PubMed ID: 1387586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line.
    Ducore JM
    Biochem Pharmacol; 1987 Jul; 36(13):2169-74. PubMed ID: 3111477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined effects of streptozotocin and mitozolomide against four human cell lines of the Mer+ phenotype.
    Gibson NW; Hartley JA; Barnes D; Erickson LC
    Cancer Res; 1986 Oct; 46(10):4995-8. PubMed ID: 2944576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced level of DNA cross-links and sister chromatid exchanges in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant rat brain tumor cells.
    Bodell WJ; Rupniak HT; Rasmussen J; Morgan WF; Rosenblum ML
    Cancer Res; 1984 Sep; 44(9):3763-7. PubMed ID: 6744295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA methyltransferase activity and sensitivity of human tumor cell lines to bis-chloroethylnitrosourea.
    Chen J; Zhang Y; Sui J; Chen Y
    Chin Med Sci J; 1992 Dec; 7(4):187-90. PubMed ID: 1339155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
    Marathi UK; Kroes RA; Dolan ME; Erickson LC
    Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
    Oredsson SM; Deen DF; Marton LJ
    Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
    Wedge SR; Porteous JK; Newlands ES
    Br J Cancer; 1996 Oct; 74(7):1030-6. PubMed ID: 8855970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Methyl-N-nitrosourea potentiation of cytogenetic damage induced by 1,3-bis(2-chloroethyl)-1-nitrosourea in normal human lymphocytes.
    Wiencke JK; Bodell WJ
    Cancer Res; 1985 Oct; 45(10):4798-803. PubMed ID: 4027969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents.
    Tokuda K; Bodell WJ
    Cancer Res; 1988 Jun; 48(11):3100-5. PubMed ID: 2835151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
    Dorr RT; Liddil JD; Gerner EW
    Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.
    Smith DC; Gerson SL; Liu L; Donnelly S; Day R; Trump DL; Kirkwood JM
    Clin Cancer Res; 1996 Jul; 2(7):1129-34. PubMed ID: 9816278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
    Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
    Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells.
    Futscher BW; Micetich KC; Barnes DM; Fisher RI; Erickson LC
    Cancer Commun; 1989; 1(1):65-73. PubMed ID: 2534817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer.
    Micetich KC; Futscher B; Koch D; Fisher RI; Erickson LC
    J Natl Cancer Inst; 1992 Feb; 84(4):256-60. PubMed ID: 1531148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.